Researchers
Discover all researchers in life sciences
Loading researchers...
Mohammad Algahtani
Consultant Of Lab Hematology at Laboratory Medicine
Clinical Trials
Crispr And Genetic Engineering
Drug Discovery
Long-Term Effects Of Covid-19
Natural Antidiabetic Agents Studies
55
Citations
4
H-index
0
Patents
9
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Mohammad Algahtani's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Computational Drug Discovery for Alzheimer's Disease
Developed and applied machine learning techniques to identify novel drugs targeting Keap1 in Alzheimer's disease, contributing to potential therapeutic strategies.
Frontiers in Molecular Neuroscience (2022)
Role of Mangiferin in Cancer Management
Investigated the role of Mangiferin in cancer treatment through the modulation of signal transduction pathways, providing insights into potential anticancer agents.
Biomedicines (2023)
CRISPR/Cas9 Genome Editing System Updates
Contributed to the understanding of CRISPR/Cas9 system advancements, focusing on novel approaches to regulate its spatiotemporal control through genetic and physicochemical strategies.
International Journal of Nanomedicine (2024)
Wheat Ergot Fungus-Derived Drug for Intracranial Aneurysm
Explored the use of a wheat ergot fungus-derived drug to inhibit intracranial aneurysm rupture, focusing on the dysfunction of the TLR-4 receptor in Alzheimer's disease.
PLoS ONE (2023)
Bioinformatics and Immunoinformatics Assisted Vaccine Construct
Utilized bioinformatics and immunoinformatics to design a multiepitope vaccine construct against Burkholderia anthina, contributing to vaccine development.
Saudi Pharmaceutical Journal (2023)
Albendazole Repurposing for Anticancer Application
Conducted in-silico analysis to explore the repurposing of Albendazole on VEGFR-2 for potential anticancer applications.
PLoS ONE (2023)
Implications of SARS-CoV-2 in Hospitalized Patients
Investigated the implications of SARS-CoV-2 infections in hospitalized patients, including co-infections and clinical outcomes.
Microorganisms (2023)
Research Highlights
Mohammad Algahtani is a consultant in Laboratory Hematology with a focus on applying computational methods and bioinformatics to drug discovery, particularly in the context of Alzheimer's disease and cancer. His research also explores the implications of CRISPR technology and COVID-19.
Research Areas
Clinical TrialsCrispr And Genetic EngineeringDrug DiscoveryLong-Term Effects Of Covid-19Natural Antidiabetic Agents Studies
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...